News
BI 1815368, a potential oral treatment to improve vision in patients with diabetic macular edema, is being investigated in a phase 2 clinical study, according to a press release from Boehringer ...
Findings could help explain the links between macular degeneration and cardiovascular disease, which both worsen with age.
Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure increasing danger of macular degeneration.
Early and intensive treatment of age-related macular degeneration with bevacizumab is associated with greater long-term improvements in visual acuity than are ranibizumab or aflibercept, a real ...
Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing neovascular age-related macular degeneration (nAMD) in older patients with ...
The Food and Drug Administration (FDA) has approved Encelto (revakinagene taroretcel-lwey) for the treatment of macular telangiectasia type 2 (MacTel).
Here's what macular degeneration is, what causes it and how you can expect it to be treated if it affects you or a loved one.
OCT angiography alone demonstrated superior sensitivity in detecting glaucomatous changes in the optic disc and macula compared with OCT and OCT angiography combined, according to a study ...
The European Medicines Agency approved Afqlir and Opuviz to treat age-related macular degeneration while reiterating its refusal of marketing authorization for Syfovre.
A supplement of antioxidant vitamins and minerals may slow the progression of dry age-related macular degeneration.
There are four stages of macular hole development. Learn more about the symptoms, treatment options, and outlook for each stage in this article.
Macula Densa Cell LLC has a patent entitled “Targeting macula densa cells as a new therapeutic approach for kidney disease” (US patents 10,828,374 and 11,318,209).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results